Abstract | BACKGROUND: METHODS: RESULTS: The median [IQR] sufentanil consumption within 24 h was lower in group OF (4[4.5]) than in group C (6[8], mean difference [MD]=-2, 95% confidence interval [ CI] [-4 to 0], P=0.029). The VAS scores at rest and during coughing at 6 h (P=0.009 at rest; P=0.002 during coughing), VAS scores during coughing at 2 h (P=0.013) and 4 h (P=0.008), EMM (P=0.026), severities of PN (P=0.003) and PV (P=0.003), and the mean time to first passage of flatus (P=0.017) was significantly less in group OF than that in group C. The prevalence of PONV (26.3% [group OF], 68.4% [group C], OR=0.31, 95% CI [0.158 to 0.589], P<0.001), use of antiemetics (5.3% [group OF], 28.9% [group C], OR=0.136, 95% CI [0.028 to 0.667], P=0.012) was also significantly different between groups. CONCLUSIONS:
|
Authors | Jiawei Chen, Qingyan Luo, Shaoqiang Huang, Jing Jiao |
Journal | Minerva anestesiologica
(Minerva Anestesiol)
Vol. 88
Issue 6
Pg. 439-447
(06 2022)
ISSN: 1827-1596 [Electronic] Italy |
PMID | 35164485
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Analgesics, Opioid
- Antiemetics
- Morphine
- Sufentanil
|
Topics |
- Analgesia
- Analgesics, Opioid
(therapeutic use)
- Anesthesia
- Antiemetics
(therapeutic use)
- Female
- Flatulence
- Gynecologic Surgical Procedures
- Humans
- Laparoscopy
- Morphine
(therapeutic use)
- Pain, Postoperative
(drug therapy)
- Postoperative Nausea and Vomiting
(epidemiology)
- Sufentanil
(therapeutic use)
|